Paper40285643
Insights into Siglec-7 Binding to Gangliosides: NMR Protein Assignment and the Impact of Ligand Flexibility.
Di Carluccio C and 15 others. Adv Sci (Weinh), 2025. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Insights into Siglec-7 Binding to Gangliosides: NMR Protein Assignment and the Impact of Ligand Flexibility. Papers, record 40285643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40285643
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Insights into Siglec-7 Binding to Gangliosides: NMR Protein Assignment and the Impact of Ligand Flexibility.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gangliosides | Major topic |
| Lectins | Major topic |
| Antigens, Differentiation, Myelomonocytic | Major topic |
| Humans | |
| Ligands | |
| Protein Binding | |
| Magnetic Resonance Spectroscopy |
Source PubMed
Grants12
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2022ZEZS45 | PRIN MUR 2022 | PubMed | ||
| P2022M457Z | PRIN MUR PNRR 2022 | PubMed | ||
| European Research Council (ERC) under the European Union's Horizon 2020 ERC-STG No 851356 | PubMed | |||
| NextGenerationEU, ITACA.SB, Project n° IR0000009), MUR 3264/2021 PNRR M4/C2/L3.1.1 | PubMed | |||
| ProgettoDipartimentidiEccellenza2023-2027toUNINAandUNIFI | Ministry of Education, Universities and Research (Italy) | PubMed | ||
PNRR, Missione 4 - Componente 2 - NextGenerationEU - Partenariato Esteso INF-ACT - One Health Basic and Translational Research Actions Addressing Unmet Needs on Emerging Infectious Diseases MUR: PE00000007 | PubMed | |||
| H2020-MSCA-ITN-2020(contractn°956758) | H2020-MSCA-ITN | PubMed | ||
| Accademia Nazionale dei Lincei | PubMed | |||
| 25-18490S | ECzech Science Foundation | PubMed | ||
| LTC20078 | Ministry of Youth, Education and Sports of the Czech Republic | PubMed | ||
| LUAUS25250 | Ministry of Youth, Education and Sports of the Czech Republic | PubMed | ||
| CA18103INNOGLY(STSM) | COST ACTION | PubMed |
Source PubMed
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31143186 | Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against Cancer. | Front Immunol | 2019 | https://conductscience.org/library/papers/31143186 | PubMed |
| 2 | 29912148 | Hypersialylation in Cancer: Modulation of Inflammation and Therapeutic Opportunities. | Cancers (Basel) | 2018 | https://conductscience.org/library/papers/29912148 | PubMed |
| 3 | 32005959 | Structural basis for Glycan-receptor binding by mumps virus hemagglutinin-neuraminidase. | Sci Rep | 2020 | https://conductscience.org/library/papers/32005959 | PubMed |
| 4 | 33248687 | The conserved arginine residue in all siglecs is essential for Siglec-7 binding to sialic acid. | Biochem Biophys Res Commun | 2021 | https://conductscience.org/library/papers/33248687 | PubMed |
| 5 | 26583988 | PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data. | J Chem Theory Comput | 2013 | https://conductscience.org/library/papers/26583988 | PubMed |
| 6 | 30245960 | Ganglioside GD3 synthase (GD3S), a novel cancer drug target. | Acta Pharm Sin B | 2018 | https://conductscience.org/library/papers/30245960 | PubMed |
| 7 | 40164254 | Insights into stability, dimerisation, and ligand binding properties of Siglec-7: Isotope labelling in HEK293 cells for protein characterisation by NMR spectroscopy. | Int J Biol Macromol | 2025 | https://conductscience.org/library/papers/40164254 | PubMed |
| 8 | 16895906 | Siglec-7 undergoes a major conformational change when complexed with the alpha(2,8)-disialylganglioside GT1b. | J Biol Chem | 2006 | https://conductscience.org/library/papers/16895906 | PubMed |
| 9 | 37910620 | Siglec-7 glyco-immune binding mAbs or NK cell engager biologics induce potent antitumor immunity against ovarian cancers. | Sci Adv | 2023 | https://conductscience.org/library/papers/37910620 | PubMed |
| 10 | 36701102 | Gangliosides as Siglec ligands. | Glycoconj J | 2023 | https://conductscience.org/library/papers/36701102 | PubMed |
| 11 | 32139317 | Sialoglycans and Siglecs Can Shape the Tumor Immune Microenvironment. | Trends Immunol | 2020 | https://conductscience.org/library/papers/32139317 | PubMed |
| 12 | 34200284 | Cancer-Associated Glycosphingolipids as Tumor Markers and Targets for Cancer Immunotherapy. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34200284 | PubMed |
| 13 | 32192217 | O-acetylated Gangliosides as Targets for Cancer Immunotherapy. | Cells | 2020 | https://conductscience.org/library/papers/32192217 | PubMed |
| 14 | 31140679 | Chemoenzymatic Synthesis of DSGb5 and Sialylated Globo-series Glycans. | Angew Chem Int Ed Engl | 2019 | https://conductscience.org/library/papers/31140679 | PubMed |
| 15 | 33430595 | Harnessing Pressure Modulation for Exploring Ligand Binding Reactions in Cosolvent Solutions. | J Phys Chem B | 2021 | https://conductscience.org/library/papers/33430595 | PubMed |
| 16 | 38848103 | Fast Quantitative Validation of 3D Models of Low-Affinity Protein-Ligand Complexes by STD NMR Spectroscopy. | J Med Chem | 2024 | https://conductscience.org/library/papers/38848103 | PubMed |
| 17 | 34869580 | Molecular Recognition Insights of Sialic Acid Glycans by Distinct Receptors Unveiled by NMR and Molecular Modeling. | Front Mol Biosci | 2021 | https://conductscience.org/library/papers/34869580 | PubMed |
| 18 | 24372645 | Ganglioside GD3 induces convergence and synergism of adhesion and hepatocyte growth factor/Met signals in melanomas. | Cancer Sci | 2014 | https://conductscience.org/library/papers/24372645 | PubMed |
| 19 | 32457377 | Discovery of a new sialic acid binding region that regulates Siglec-7. | Sci Rep | 2020 | https://conductscience.org/library/papers/32457377 | PubMed |
| 20 | 25623398 | Functional Siglec lectin domains from soluble expression in the cytoplasm of Escherichia coli. | Protein Expr Purif | 2015 | https://conductscience.org/library/papers/25623398 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41924269 | Siglec-7 inhibits TLR3-induced pro-inflammatory cytokine production from human monocytes and macrophages. | Front Immunol | 2026 | https://conductscience.org/library/papers/41924269 | PubMed |
| 41889736 | Fusobacterium nucleatum Lipopolysaccharides Disrupt the Interaction of Siglec‑7 to Sialoglycans Expressed on Mammalian Cells. | JACS Au | 2026 | https://conductscience.org/library/papers/41889736 | PubMed |
| 41651416 | Writers and readers of sialylation in immunoregulation in cancer. | J Biol Chem | 2026 | https://conductscience.org/library/papers/41651416 | PubMed |
| 41311924 | Fusobacterium nucleatum Lipopolysaccharides O‑Antigen Defines a Novel Siglec‑7 Binding Epitope. | JACS Au | 2025 | https://conductscience.org/library/papers/41311924 | PubMed |
| 40443894 | Molecular Basis of Siglec‑7 Recognition by Neisseria meningitidis Serogroup Y CPS: Implications for Immune Evasion. | JACS Au | 2025 | https://conductscience.org/library/papers/40443894 | PubMed |
| 40285643 | Insights into Siglec-7 Binding to Gangliosides: NMR Protein Assignment and the Impact of Ligand Flexibility. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40285643 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| A4GALT | 53947 | PubTator's text mining | https://conductscience.org/library/genes/53947 | NCBI Gene |
| GRDX | 117189 | PubTator's text mining | https://conductscience.org/library/genes/117189 | NCBI Gene |
| SIGLEC7 | 27036 | PubTator's text mining | https://conductscience.org/library/genes/27036 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40285643
GET https://conductscience.org/api/papers/v1/40285643/references?page=2